ZNF555 Inhibitors

Chemical inhibitors of ZNF555 utilize various mechanisms to disrupt its function. Disulfiram, Clioquinol, 1,10-Phenanthroline, TPEN, and Cadmium chloride target the zinc finger domains that are crucial for the DNA-binding capability of ZNF555. Disulfiram and Clioquinol act as metal chelators, sequestering zinc ions and therefore destabilizing the zinc finger motifs. This loss of zinc disrupts the structural integrity needed for ZNF555 to engage with DNA effectively. 1,10-Phenanthroline extends this disruption by chelating metal ions, leading to a compromised DNA binding. Similarly, TPEN removes zinc ions from ZNF555, triggering a conformational change and functional inhibition. Cadmium chloride can substitute zinc in the zinc finger motifs, potentially leading to misfolded and functionally inactive ZNF555.

Ebselen, Thiomersal, and Withaferin A interfere with the protein's structure through their interactions with cysteine residues. Ebselen's reactivity towards cysteine residues may lead to a conformational change that inhibits ZNF555's activity. Thiomersal binds to sulfhydryl groups within cysteine-rich domains, altering ZNF555's structure and inhibiting its function. Withaferin A binds to cysteine residues as well, and it is presumed to interfere with the correct formation of zinc finger domains within ZNF555. Pyrithione zinc disrupts zinc homeostasis, which can result in a zinc deficiency for ZNF555, further inhibiting its function. MG132 adds another layer of inhibition by targeting the ubiquitin-proteasome pathway, leading to the accumulation of misfolded ZNF555 proteins, which reduces its functional population. Triptolide inhibits transcription factors that are necessary for the regulatory functions of ZNF555, leading to its inhibition. Finally, PAC-1, by activating caspase-3, can lead to the degradation of ZNF555, effectively inhibiting its presence in the cell.